4.7 Article

Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Surgery

Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival

Michael R. Poulson et al.

Summary: Analyzing data from 2005 to 2015, the study found that Black patients have a higher risk of presenting at advanced stage, receiving surgery for localized disease, and decreased survival rate compared to White patients as segregation increases. These results highlight the significant association between residential racial segregation and Black-White disparities in breast cancer outcomes.

ANNALS OF SURGERY (2021)

Article Oncology

Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area

Lindsay J. Collin et al.

Summary: The study revealed that living in redlined areas significantly increases breast cancer mortality, while residing in areas with pronounced lending bias decreases breast cancer mortality. Non-Hispanic Black and Non-Hispanic White women experience different levels of mortality under these influences, highlighting the need for further research.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy

Mohamed Abdelgadir Adam et al.

Summary: This study found that the use of neoadjuvant chemotherapy (NAC) can compensate for the survival disadvantage caused by omission of adjuvant chemotherapy (AC) for resected pancreatic adenocarcinoma patients. NAC is associated with improved overall survival for patients who did not receive AC, and the median overall survival for these patients is comparable to those who received AC alone.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Surgery

Racial Disparities in the Use of Surgical Procedures in the US

Matthew J. Best et al.

Summary: This study analyzed the national rates of use for 9 major surgical procedures from 2012 to 2017 to determine whether national initiatives have improved racial disparities in the use of surgical procedures in the US. The results showed that racial disparities persisted for all analyzed procedures and worsened for one-third of them, regardless of US census division, hospital teaching status, or insurance status. Further efforts are needed to reduce these disparities and improve healthcare equality.

JAMA SURGERY (2021)

Article Surgery

Neoadjuvant Therapy for Resectable Pancreatic Cancer A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials

Dominique L. Birrer et al.

Summary: The study found that neoadjuvant therapy can improve disease-free survival in patients with resectable pancreatic ductal adenocarcinoma, without negatively impacting surgical outcomes. Although patients experienced higher toxicity after neoadjuvant therapy, they had lower rates of postoperative complications, making it a viable option for purely resectable PDAC patients.

ANNALS OF SURGERY (2021)

Editorial Material Medicine, General & Internal

Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals

Annette Flanagin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis

Wilson Luiz da Costa et al.

Summary: This study found that neoadjuvant therapy (NAT) is associated with improved survival in patients with resectable pancreatic ductal adenocarcinoma (PDAC) compared to upfront resection.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Completion of adjuvant therapy in patients with resected pancreatic cancer

Danielle K. DePeralta et al.

Article Oncology

Pancreatic Adenocarcinoma, Version 1.2019

Margaret A. Tempero et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Review Oncology

Social determinants of breast cancer risk, stage, and survival

Steven S. Coughlin

BREAST CANCER RESEARCH AND TREATMENT (2019)

Review Oncology

Optimizing the outcomes of pancreatic cancer surgery

Oliver Strobel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Public, Environmental & Occupational Health

Disparities in Pancreatic Cancer Treatment and Outcomes

Marcus Noel et al.

HEALTH EQUITY (2019)

Editorial Material Surgery

A Checklist to Elevate the Science of Surgical Database Research

Adil H. Haider et al.

JAMA SURGERY (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Surgery

National disparities in minimally invasive surgery for pancreatic tumors

Emmanuel Gabriel et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)

Article Gastroenterology & Hepatology

Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?

Katherine T. Ostapoff et al.

Article Oncology

Clinical Management: Resectable Disease

Rebekah R. White et al.

CANCER JOURNAL (2017)

Article Surgery

Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care?

Andrew P. Loehrer et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)

Editorial Material Oncology

Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy

Davendra P. S. Sohal et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Oncology

Disparities in Pancreas Cancer Care

Anasooya Abraham et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

Article Surgery

Who Receives Their Complex Cancer Surgery at Low-Volume Hospitals?

Waddah B. Al-Refaie et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)

Article Health Care Sciences & Services

Racial/Ethnic Patterns of Care for Pancreatic Cancer

Vickie L. Shavers et al.

JOURNAL OF PALLIATIVE MEDICINE (2009)

Article Medicine, General & Internal

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

JP Neoptolemos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)